Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bupivacaine-epinephrine 0.25%-1:200,000 injectable solution plus clonidine1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
2Bupivacaine/epinephrine/dexamethasone1件: Bupivacaine2件: Bupivacaine hydrochloride ,
Bupivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 96 💬
3Epinephrine1件: Epinephrine (Epinephrine)3件: Epinephrine (Epinephrine, CERTA DOSE EPINEPHRINE CONVENIENCE KIT, EPINEPHRINE, EPINEPHRINE CONVENIENCE KIT, EPINEPHRINE 0.15 PEDIATRICS, EPINEPHRINE 0.3 ADULTS, EPINEPHRINE PEDIATRICS),
Epinephrine hydrochloride (Epinephrine hydrochloride),
Epinephrine bitartrate (Epinephrine bitartrate, EPINEPHRINE) 💬 		9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
4LAP TAP bupivacaine/epinephrine----2件: 96, 97 💬
5Ropivacaine, epinephrine, clonidine, and ketorolac injection cocktail1件: Ropivacaine2件: Ropivacaine hydrochloride ,
Ropivacaine 💬 		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 70 💬
6US TAP bupivacaine/epinephrine----2件: 96, 97 💬